atai Life Sciences is a pharmaceutical company that is developing psychedelics, other hallucinogens, entactogens, and related drugs for treatment of psychiatric conditions. [1][2][3][4][5] It was founded in …

Aug 15, 2025 · Planned strategic combination between atai Life Sciences and Beckley Psytech Limited to create a global leader in short in-clinic psychedelic-based mental health therapies is expected to …

Dec 25, 2025 · Atai Beckley (ATAI) has quietly become one of the more talked about mental health biotech names this year, with the stock swinging sharply even as its late stage psychedelic pipeline …

May 14, 2025 · With clinical momentum across its pipeline, atai strengthens its position as a leader in potentially transformative psychedelic mental health treatments. Cash, cash equivalents, short-term...

4 days ago · ATAI Life Sciences N.V. has set terms for its initial public offering, in which the Germany-based biopharmaceutical company focused on mental health disorders looks to raise up to $214.3...

4 days ago · A detailed overview of Atai Beckley N.V. (ATAI) stock, including real-time price, chart, key statistics, news, and more.

3 days ago · AtaiBeckley, formed through the merger of ATAI Life Sciences N.V. and Beckley Psytech Limited, is advancing therapies for treatment-resistant depression and other mental health disorders, …

Jun 2, 2025 · Atai Life Sciences, among the most prominent biotechs focused on psychedelic medicines, said Monday it will merge with private psychedelic startup Beckley Psytech, pending results of a trial...

On Friday 12/26/2025 the closing price of the ATAI Life Sciences N.V. Registered Shs share was $4.20 on BTT. Compared to the opening price on Friday 12/26/2025 on BTT of $4.19, this is a gain...

Aug 14, 2025 · What were the key findings from atai Life Sciences' BPL-003 Phase 2b trial for treatment-resistant depression? The trial met primary and all key secondary endpoints, showing …